Wird geladen...
How I treat adverse effects of CAR-T cell therapy
Chimeric antigenreceptor (CAR) T cell therapy has demonstrated efficacy in B cell malignancies, particularly for acute lymphoblastic leukaemia (ALL) and non‑Hodgkin lymphomas. However, this regimen is not harmless and, in some patients, can lead to a multi organ failure. For this reason, the knowled...
Gespeichert in:
| Veröffentlicht in: | ESMO Open |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Publishing Group
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7451454/ https://ncbi.nlm.nih.gov/pubmed/32839196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2020-000746 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|